Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech

By:
On:
URL has been copied successfully!
Global pharmaceutical companies are aggressively searching for new medicines in China
Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here